A6. A006 HOT TAKES FROM CLINICAL TRIALS IN LUNG DISEASE

Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by GAP Stage

Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1026 C. Ryerson, N. Chaudhuri, E. F. Fernández Pérez, Y. Kim, R.S. Silva, W. Wuyts, H. Müller, K. Rohr, M. Kolb

Long-Term Follow-up of Severe Emphysema Patients Treated with Zephyr Valves in the Multicenter, Randomized TRANSFORM Study

Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1023 D. Slebos, M. Kornaszewska, S. Kemp, A. Kirk, K. Carron, H. Mal, C. Pison, N. Downer, K. Darwiche, J. Rao, Ralph-Harto Hubner, V. Trosini-Desert, R. Eberhardt, E. Derom, C. Marquette, N. Shargill, P. Shah

Improvements in Cough Frequency Over 24 Hours with BLU-5937, a Selective P2X3 Antagonist, in Patient Subgroups Defined by Baseline Awake Cough Frequencies

Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1019 J. Smith, A. Morice, S. Birring, S. Parker, P. Marsden, J. Holcomb, B. Prenner, M. Sher, G. Steven, L. Mcgarvey, D. Garceau, C. Bonuccelli, L. Harvey